Antengene Corporation Raises $120 Million in Series B Financing
SHANGHAI and SHAOXING, Jan. 2, 2019 /PRNewswire-AsiaNet/ -- Antengene Corporation (Antengene), a clinical stage therapeutics company focused on oncology, announced today that it has completed a $120 million Series B financing. The Series B financing was jointly led by Boyu Capital and FountainVest, with pa...
Read more https://view-release/?pr-id=76918